Pfizer's stock has recently struggled but remains a bargain with generous dividends. Is now a good time to invest in PFE?

If you're looking for reasonably priced stocks to pick up right now, you shouldn't overlook Pfizer (NYSE: PFE). The ...

Of late, pharmaceutical behemoth Pfizer Inc.’s PFE stock has struggled, but it remains a bargain with generous dividends. Its ...

Obesity remains a significant public health challenge in the UK, with over 26% of adults classified as obese and an ...

In 2024, Pfizer generated free cash flow of $9.8 billion, which was more than the $9.5 billion it paid out in dividends. 3. The company looks to still be in acquisition mode Pfizer previously told ...

Pfizer (PFE) stock in focus as the company sells its entire 7.3% stake in Haleon (HLN) for $3.24B. Read more here.

Equities research analysts at Zacks Research reduced their Q2 2026 earnings per share (EPS) estimates for Pfizer in a report issued on Thursday, March 20th. Zacks Research analyst K. Shah now ...

Pfizer's attractive dividend yield and low P/E ratio make it appealing. Learn why PFE stock's valuation risks may be higher ...

Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares.